论文部分内容阅读
莫斯科省临床科学研究院泌尿科临床治疗院自1950年1月开始采用组织疗法治疗尿道狭窄,二年内计对36名病人实施了组织疗法。病人分为三组:(1)第一组5名是单纯用储藏的脾脏组织埋植治疗;(2)第二组16名除埋植外併用尿道探子扩张;(3)第三组15名除埋植外并施行了尿道手术。第二组中8名病人在组织埋植前任何器械不能插入尿道,5名只能通过12号尿道探子,3名通过16号尿道探子。但於脾组织埋植後,可通过尿道探子12号者2名,16号者3名,18号者8名,20号者2名及25号者3名。在治疗中获得良好的效果,是由於组织埋植
Department of Urology, Moscow State Academy of Clinical Sciences has been using tissue therapy to treat urethral strictures since January 1950 and has performed tissue therapy in 36 patients over two years. The patients were divided into three groups: (1) the first group of 5 patients were treated with implanted spleen tissue alone; (2) the second group of 16 patients underwent splenectomy with urethral catheterization; (3) the third group of 15 In addition to implantation and the implementation of urethral surgery. Eight patients in the second group were unable to insert the urethra in any of the devices prior to tissue implants, five only through the No. 12 urethral probe and three through the No. 16 urethral probe. However, after the spleen tissue is implanted, there are 2 people who can pass the urethral probe No. 12, three of No. 16, eight of No. 18, two of No. 20, and three of No. 25. Good results in treatment are due to tissue engraftment